Treatment of COVID-19 disease in pregnancy and breastfeeding

The physiological and anatomical clinical characteristics of pregnant women make them susceptible to complications caused by coronavirus disease (COVID-19). Increased coagulation risk thromboembolic phenomena are common during pregnancy; they further enhanced when associated with a thrombogenic pathology such as in COVID-19. treatment COVID-19 is controversial limited, even for non-pregnant patients. During pregnancy, the options more restricted due teratogenicity some drugs difficulties, especially advanced pregnancy patients respiratory failure. Therefore, focus should be centered on isolation, monitoring fetal maternal vital signs, uterine activity, general maternal-fetal well-being. prescription management orientation based gestational age conditions. optimal type delivery guided obstetric indications severity. Breastfeeding encouraged use masks hand hygiene. brings important peculiarities that considered order better decisions preserving health mother fetus.